Over the last 90 days, Avalyn Pharma Inc. has seen significant insider buying activity, with a total buy value of $24,999,984 and no reported sells. Three net buying insiders were recorded. Notable transactions include substantial purchases by SR ONE CAPITAL MANAGEMENT, LLC and Novo Holdings A/S, alongside a purchase by insider Jill Carroll.